Opinion

Sam Cooper founded Phenomic AI in 2017 alongside Oren Kraus, as an early stage biotech company seeking to commercialise AI approaches for pharmaceutical R&D. He discusses the role of AI in drug discovery with Lu Rahman. LR: Where are we with deep learning and drug discovery and how effective is it for researchers? How well […]

Says Lu Rahman, DDW Editor in Chief I’ll admit it’s pretty hard right now to come up with one, let alone multiple reasons to be cheerful. As I write this from my desk in the north of the UK, it’s bitterly cold, our schools have been closed (along with everywhere else you might see another […]

By Dr Steve Arlington, President, The Pistoia Alliance COVID-19 has dealt the life sciences a host of challenges, but it’s also been the catalyst for positive change. As the industry has turned its resources towards developing critical vaccines and therapies, organisations, governments, regulators, researchers and academia have come together in ways never seen before. In […]

Dr Elizabeth Fairley, COO and co-founder of social intelligence company Talking Medicines, explains how technology has shaped the drug landscape and why actually listening to patients might be the breakthrough the industry needs. There are more drugs on the market today than ever before and the drug pipeline is massively more accelerated than it was […]

Rutgers Research Professor, Daniel Hausman, examines the ethical questions around human challenge trials for COVID-19 vaccines The first human challenge trial to test COVID-19 treatments and vaccines is set to begin in January in the United Kingdom. These trials, in which healthy volunteers are infected with the virus after being given different vaccines under development, […]

Orexo recently launched the digital therapies deprexis and vorvida in the US. Lu Rahman talked to Nikolaj Sørensen, President and CEO about these therapies and the company’s expertise LR: Explain how digital therapies work and the type of conditions they are most suited to treat. NS: Digital therapeutics are evidence-based therapeutic interventions driven by high-quality […]

The Jefferies Healthcare Temperature Check report is now in its third edition and published to coincide with the 11th annual Global Healthcare Conference which was held virtually. Over 500 responses from senior leaders in the sector responded for this year’s report, giving views on both the current state of the market and predictions for 2021. […]

Mike Rea is CEO of IDEA Pharma. Over the last 20 years he has worked on a range of successful new drug launches. He recently turned his hand to writing with the publication of his book Pharmaceutical Positioning. Lu Rahman found out more about this topic and why drug developers should be thinking about it […]

Richard Torbett, Chief Executive, ABPI says vaccines are one of our best hopes for eradicating COVID-19 and why the ABPI is launching a campaign to highlight this. “COVID-19 has put shone a spotlight on the pharmaceutical industry like never before. Millions of people all over the world are living under some form of restrictions.  The […]